NEW YORK (GenomeWeb) – Berry Genomics announced today that it has formed a collaboration with BioNano Genomics to develop assays for the detection of chromosomal variations for the Chinese market.

Under the terms of their deal, the companies will co-develop assays that incorporate BioNano's Irys next-generation mapping platform, which is designed to image, map, and analyze DNA at the single-molecule level to reveal structural variation and aid in genome assembly.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.